CRIS Current Research Information System

RAPEZZI, CLAUDIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.977
EU - Europa 11.109
AS - Asia 5.454
AF - Africa 733
SA - Sud America 37
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 5
Totale 33.338
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.933
GB - Regno Unito 3.064
IT - Italia 2.149
CN - Cina 1.942
DE - Germania 1.440
SE - Svezia 1.432
SG - Singapore 1.343
VN - Vietnam 1.294
RU - Federazione Russa 680
UA - Ucraina 595
IN - India 578
IE - Irlanda 479
FR - Francia 421
EE - Estonia 260
ZA - Sudafrica 247
TG - Togo 215
CI - Costa d'Avorio 168
BG - Bulgaria 127
JO - Giordania 110
BE - Belgio 87
FI - Finlandia 87
CH - Svizzera 82
NG - Nigeria 70
IR - Iran 52
CA - Canada 40
GR - Grecia 40
NL - Olanda 40
PL - Polonia 35
JP - Giappone 32
SC - Seychelles 31
BR - Brasile 19
HK - Hong Kong 19
AT - Austria 18
AU - Australia 18
KR - Corea 13
LB - Libano 13
ID - Indonesia 12
RO - Romania 12
HR - Croazia 10
UZ - Uzbekistan 10
CL - Cile 8
LT - Lituania 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AL - Albania 5
AR - Argentina 5
DK - Danimarca 5
ES - Italia 5
HU - Ungheria 5
MD - Moldavia 5
MY - Malesia 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
CZ - Repubblica Ceca 4
LU - Lussemburgo 4
PE - Perù 4
TH - Thailandia 4
TR - Turchia 4
BD - Bangladesh 3
GE - Georgia 3
IL - Israele 3
AE - Emirati Arabi Uniti 2
MX - Messico 2
PK - Pakistan 2
PT - Portogallo 2
SA - Arabia Saudita 2
SM - San Marino 2
AM - Armenia 1
AZ - Azerbaigian 1
BZ - Belize 1
EC - Ecuador 1
EG - Egitto 1
HT - Haiti 1
IS - Islanda 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
ME - Montenegro 1
MN - Mongolia 1
MU - Mauritius 1
NP - Nepal 1
PH - Filippine 1
RS - Serbia 1
Totale 33.338
Salva come PNG Salva come JPEG
Città #
Southend 2.757
Fairfield 2.123
Chandler 1.358
Ashburn 1.285
Singapore 1.184
Woodbridge 1.081
Houston 968
Seattle 925
Wilmington 888
Dong Ket 771
Cambridge 770
Ann Arbor 765
Santa Clara 737
Princeton 668
Dublin 478
Boardman 421
Jacksonville 316
Westminster 298
Padova 277
Nanjing 276
Bologna 248
Lomé 215
Berlin 200
Abidjan 168
Saint Petersburg 167
Bremen 156
Beijing 147
New York 144
Turin 127
Milan 126
Sofia 124
Jinan 123
Shenyang 120
Amman 109
San Diego 109
Dearborn 98
Nanchang 94
Rome 90
Hebei 87
Changsha 86
Brussels 85
Helsinki 83
Abeokuta 69
Tianjin 66
Los Angeles 63
Bern 62
Jiaxing 62
Medford 62
Mülheim 61
Guangzhou 59
Zhengzhou 49
Florence 46
Des Moines 45
Haikou 44
Munich 44
Norwalk 43
Yubileyny 43
Falls Church 40
Redwood City 40
Naples 39
Redmond 39
Olalla 38
Shanghai 35
Hangzhou 34
Ningbo 31
Taiyuan 31
Mahé 30
Chicago 28
Phoenix 28
Taizhou 28
Kuban 26
London 26
Verona 26
Kunming 25
Lanzhou 24
Brescia 23
Warsaw 23
Washington 23
Fuzhou 21
Paris 21
Tokyo 21
Bühl 20
Leawood 19
Mountain View 19
Bari 18
Hefei 18
Pune 18
Toronto 18
Xi'an 18
Chengdu 17
Shenzhen 17
Wuhan 17
Zanjan 17
San Venanzo 16
Napoli 15
San Francisco 15
São Paulo 14
Frankfurt am Main 13
Moscow 13
Andover 12
Totale 23.084
Salva come PNG Salva come JPEG
Nome #
Linee guida ESC 2015 per il trattamento dell'endocardite infettiva: Task Force per il Trattamento dell'Endocardite Infettiva della Società Europea di Cardiologia (ESC): Con il patrocinio dell'Associazione Europea di Chirurgia Cardiotoracica (EACTS) e dell'Associazione Europea di Medicina Nucleare (EANM) 567
ATEROMASIA DELL'ARCO AORTICO COME FATTORE PREDITTIVO DI EMBOLIA CEREBRALE DURANTE LE PROCEDURE DI STENTING CAROTIDEO. STUDIO PROSPETTICO CON ECOCARDIODOPPLER TRANSESOFAGEO A DIFFUSIONE E RISONANZA MAGNETICA 458
Acute heart failure in patients with acute aortic syndrome: Pathophysiology and clinical-prognostic implications 233
Ventricular remodeling in Loeffler endocarditis: Implications for therapeutic decision making. 228
Acute and chronic haemodynamic effects of biventricular pacing and of switching to different pacing modalities in heart failure patients 224
Sempre oscura mi fu quest'aVR. L'insospettabile ricchezza di una derivazione dimenticata 198
(18)F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis. 187
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy 183
Atrial fibrillation in amyloidotic cardiomyopathy: Prevalence, incidence, risk factors and prognostic role 182
Effects of myocardial fibrosis assessed by MRI on dynamic left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy: a retrospective database analysis. 179
Antithrombotic Management during Percutaneous Mitral Valve Repair with the Mitraclip System in a Patient with Heparin-Induced Thrombocytopenia 175
Combined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: A case series 174
Amiloidosi ereditaria da mutazione della transtiretina: caratterizzazione dei casi con interessamento cardiaco esclusivo o prevalente 172
Carotid revascularization in patients with ongoing oral anticoagulant therapy: the advantages of stent placement. 169
The absence of dystrophin brain isoform expression in healthy human heart ventricles explains the pathogenesis of 5' X-linked dilated cardiomyopathy 168
Parodoxical contributions of non-compacted and compacted segments to global left ventricular dysfunction in isolated left ventriculat noncompaction 167
An unusual case of a congenital aorto-left atrial tunnel. 165
Clinical characteristics of wild-type transthyretin cardiac amyloidosis: Disproving myths 163
Baseline white blood cell count is an independent predictor of long-term cardiovascular mortality in patients with non-ST-segment elevation acute coronary syndrome, but it does not improve the risk classification of the GRACE score. 162
Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis. 162
Does the etiology of cardiac amyloidosis determine the myocardial uptake of [18F]-NaF PET/CT? 162
Arrhythmia discrimination by physician and defibrillator: importance of atrial channel. 160
Adherence to agents acting on the renin-angiotensin system in secondary prevention of non-fatal myocardial infarction: a self-controlled case-series study 160
Accuracy of non-invasive techniques for diagnosis of coronary artery disease and prediction of cardiac events in patients with left bundle branch block: a meta-analysis. 159
Cardiac resynchronization therapy: variations in echo-guided optimized atrioventricular and interventricular delays during follow-up. 159
Noninvasive etiologic diagnosis of cardiac amyloidosis using (99m)tc-3,3-diphosphono-1,2-propanodicarboxylic Acid scintigraphy. 157
Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis 157
Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation 156
Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. 153
Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective 152
Noninvasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. 151
Phenotypic and genotypic heterogeneity in transthyretin-related cardiac amyloidosis: Towards tailoring of therapeutic strategies? 150
Vascular complications after balloon aortic valvuloplasty in recent years: Incidence and comparison of two hemostatic devices 149
Atherosclerotic aortic lesions increase the risk of cerebral embolism during carotid stenting in patients with complex aortic arch anatomy. 147
Different types of cardiomyopathy associated with isolated ventricular noncompaction 147
Risk Factors for diagnostic delay in acute aortic dissection. 146
Assessment of mitral regurgitation through Doppler echocardiography: Feasibility, pitfalls and diagnostic advantages 146
Skin globotriaosylceramide 3 deposits are specific to Fabry disease with classical mutations and associated with small fibre neuropathy. 146
The elusive link between aortic wall histology and echocardiographic anatomy in bicuspid aortic valve: implications for prophylactic surgery 144
Balloon aortic valvuloplasty as a bridge-to-decision in high risk patients with aortic stenosis: A new paradigm for the heart team decision making 144
Cardiac involvement in hereditary-transthyretin related amyloidosis. 144
Usefulness and limitations of (99m)Tc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy. 142
Age and heart transplantation: results from a heart failure management unit. 142
Cardiac amyloidosis: the great pretender 141
Coexistence of Degenerative Aortic Stenosis and Wild-Type Transthyretin-Related Cardiac Amyloidosis 139
Utility of stress perfusion-cardiac magnetic resonance in follow-up of patients undergoing percutaneous coronary interventions of the left main coronary artery 138
Prognostic stratification of patients with right bundle branch block using dobutamine stress echocardiography. 137
Troponin T elevation in acute aortic syndromes: Frequency and impact on diagnostic delay and misdiagnosis 137
Incidence, treatment, and outcome of acute aortic valve regurgitation complicating percutaneous balloon aortic valvuloplasty 136
Cardiac FDG PET/CT is useful to assess the culprit lesion in nonST-segment elevation myocardial infarction (NSTEMI). 136
Cardiac resynchronization therapy: a comparison among left ventricular bipolar, quadripolar and active fixation leads 136
Analogies and disparities among scintigraphic bone tracers in the diagnosis of cardiac and non-cardiac ATTR amyloidosis 136
Diagnostic performance of standard electrocardiogram for prediction of infarct related artery and site of coronary occlusion in unselected STEMI patients undergoing primary percutaneous coronary intervention 136
The residual risk of cerebral embolism after carotid stenting: the complex interplay between stent coverage and aortic arch atherosclerosis. 134
New pathological insights into cardiac amyloidosis: implications for non-invasive diagnosis. 134
Brain microbleeds 12 Years after orthotopic liver transplantation in Val30Met amyloidosis 133
Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. 133
Amyloidosis. Also a heart disease 132
Clinical use of doppler echocardiography in organic mitral regurgitation: From diagnosis to patients’ management 132
Prognostic stratification and treatment of cardiac light chain amyloidosis: a narrow path in the jungle. 131
Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction 129
Prenatal echographic recognition of hypertrophic cardiomyopathy leading to heart transplantation in the newborn. 129
Functional correlates of N-terminal natriuretic peptide type B (NT-proBNP) response to therapy in cardiac light chain (AL) amyloidosis. 129
Diagnosi e terapia in cardiologia : l'essenziale a portata di mano 129
Incidence, treatment and outcome of acute coronary syndromes: A community-based study in the era of myocardial infarction networks. 129
Biolimus-A9 eluting stent implantion for unprotected left main coronary artery stenosis: 9-month strut coverage as assessed by optical coherence tomography 129
Prognostic significance of shockable and non-shockable cardiac arrest in ST-segment elevation myocardial infarction patients undergoing primary angioplasty 128
Exercise stress echocardiography is superior to rest echocardiography in predicting left ventricular reverse remodelling and functional improvement after cardiac resynchronization therapy. 128
Prodromal angina and risk of 2-year cardiac mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention 128
Coronary artery disease and reasonably incomplete coronary revascularization in high-risk patients undergoing transcatheter aortic valve implantation 128
Etiology of amyloidosis determines myocardial 99mTc-DPD uptake in amyloidotic cardiomyopathy 128
Defining the diagnosis in echocardiographically suspected senile systemic amyloidosis. 128
Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies 128
How, why, and when may atrial defibrillation find a specific role in implantable devices? A clinical viewpoint. 127
Comparison of ventricular long-axis function in patients with cardiac amyloidosis versus idiopathic restrictive cardiomyopathy. 127
Cardiac resynchronization therapy in clinical practice: Need for electrical, mechanical, clinical and logistic synchronization. 127
Electrocardiographic Eligibility for Subcutaneous Implantable Cardioverter Defibrillator: Evaluation during Bicycle Exercise 126
Short- and long-term prognostic significance of ST-segment elevation in lead aVR in patients with non-ST-segment elevation acute coronary syndrome. 126
Cardiac FDG PET/CT to Assess the Culprit Lesion during Acute Infarction 126
Genotype-phenotype correlations in amyloidotic cardiomyopathy. 125
Long-term outcome and risk stratification in dilated cardiolaminopathies 125
Identification of TTR-Related Subclinical Amyloidosis With 99mTc-DPD Scintigraphy 125
Dilated-Hypokinetic evolution of hypertrophic cardiomyopathy 125
Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy 125
Safety and efficacy of early aggressive versus cholesterol-driven lipid-lowering strategies in heart transplantation: A pilot, randomized, intravascular ultrasound study. 125
Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: Long-term follow-up of the SHIRAKISS randomized, prospective study. 124
Predictors of complicated athero-thrombotic lesions in non-ST segment acute coronary syndrome. 124
The empowerment of translational research: lessons from laminopathies. 124
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 124
What is the acceptable rate of false positives for STEMI within a primary PCI network? Insights from a metropolitan system with direct ambulance-based access. 123
C-reactive protein and embolization during carotid artery stenting. a serological and morphological study 122
Frequency, determinants, and clinical relevance of acute coronary syndrome-like electrocardiographic findings in patients with acute aortic syndrome 122
Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. 122
Phenotypic profile of Ile68Leu transthyretin amyloidosis: an underdiagnosed cause of heart failure 122
Significance of magnetic resonance imaging in apical hypertrophic cardiomyopathy. 121
Inferior Q waves in apparently healthy subjects: Should we take a deep breath? An electrocardiographic, echocardiographic and cardiac magnetic resonance study 121
Aortic thrombosis: a shared complication of different underlying diseases 121
Genotypic and phenotypic correlation in an Italian population of hereditary amyloidosis TTR-related (HA-TTR): clinical and neurophysiological aids to diagnosis and some reflections on misdiagnosis 121
Transthyretin-related amyloidoses and the heart: a clinical overview. 120
Anticoagulant drugs in noncompaction: A mandatory therapy? 120
Totale 15.100
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.715
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.715
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.845 0 0 0 0 0 0 1.113 1.178 1.133 616 319 486
2020/20214.509 908 309 179 182 77 186 65 251 444 216 201 1.491
2021/20225.728 503 284 368 541 528 326 157 364 235 358 1.109 955
2022/20236.374 639 860 356 920 482 490 163 355 1.159 181 456 313
2023/20241.768 118 318 142 161 149 416 95 72 46 121 66 64
2024/20253.977 255 1.032 532 540 1.079 270 269 0 0 0 0 0
Totale 34.177